Nanoform significantly strengthens commercial organisation with Chief of Business Operations appointment
Nanoform, an innovative drug enabling nanotechnology company, has appointed Dr Gonçalo Rebelo de Andrade as Chief of Business Operations.
Nanoform continues rapid expansion with construction of GMP manufacturing plant
Nanoform, an innovative drug enabling nanotechnology company, has announced the construction of a GMP manufacturing plant to provide API ‘solution to particle’ nanonization for clinical trials.
Nanoform set to globalize its technology with appointment of a Chief Commercial Officer
Nanoform, a Helsinki, Finland-based drug particle engineering and nanotechnology company, is set to globalize its novel nanonization technology with the appointment of Christian Jones as Chief Commercial Officer.
Nanoform set to transform drug development through €7 million investment in patented nanoparticle technology
Nanoform, an innovative drug particle engineering and nanotechnology company that provides novel API particle-size reduction services, is continuing its strategic growth through a significant €7 million investment, with Vator Securities acting as the sole bookrunner.